Artigos de revistas sobre o tema "Chromodomain Helicase DNA binding 4 (CHD4)"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 47 melhores artigos de revistas para estudos sobre o assunto "Chromodomain Helicase DNA binding 4 (CHD4)".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Kolla, Venkatadri, Koumudi Naraparaju, Tiangang Zhuang, Mayumi Higashi, Sriharsha Kolla, Gerd A. Blobel e Garrett M. Brodeur. "The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex". Biochemical Journal 468, n.º 2 (22 de maio de 2015): 345–52. http://dx.doi.org/10.1042/bj20150030.
Texto completo da fonteSillibourne, James Edward, Bénédicte Delaval, Sambra Redick, Manisha Sinha e Stephen John Doxsey. "Chromatin Remodeling Proteins Interact with Pericentrin to Regulate Centrosome Integrity". Molecular Biology of the Cell 18, n.º 9 (setembro de 2007): 3667–80. http://dx.doi.org/10.1091/mbc.e06-07-0604.
Texto completo da fonteLin, Shiaw-Yih, Jing Zhang e David J.H. Shih. "The Tale of CHD4 in DNA Damage Response and Chemotherapeutic Response". Cancer Research and Cellular Therapeutics 3, n.º 1 (8 de julho de 2019): 01–03. http://dx.doi.org/10.31579/2640-1053/052.
Texto completo da fonteHagman, James, Carissa Dege, Desiree Straign, Haiqun Jia, Kendra Walton, Kara Lukin, Hong Lei, Thomas Danhorn e Ann Feeney. "Chromodomain helicase DNA-binding 4 is required for proliferation, distal VH rearrangements and developmental progression of B cell progenitors (HEM1P.221)". Journal of Immunology 194, n.º 1_Supplement (1 de maio de 2015): 50.4. http://dx.doi.org/10.4049/jimmunol.194.supp.50.4.
Texto completo da fonteChohra, Ilyas, Subhajit Giri e Brigitte Malgrange. "Generation of a Well-Characterized Homozygous Chromodomain-Helicase-DNA-Binding Protein 4G1003D Mutant hESC Line Using CRISPR/eCas9 (ULIEGEe001-A-1)". International Journal of Molecular Sciences 24, n.º 13 (23 de junho de 2023): 10543. http://dx.doi.org/10.3390/ijms241310543.
Texto completo da fonteLarsen, Dorthe Helena, Catherine Poinsignon, Thorkell Gudjonsson, Christoffel Dinant, Mark R. Payne, Flurina J. Hari, Jannie M. Rendtlew Danielsen et al. "The chromatin-remodeling factor CHD4 coordinates signaling and repair after DNA damage". Journal of Cell Biology 190, n.º 5 (30 de agosto de 2010): 731–40. http://dx.doi.org/10.1083/jcb.200912135.
Texto completo da fonteHosokawa, Hiroyuki, Tomoaki Tanaka, Miki Kato, Yuuki Tamaki e Toshinori Nakayama. "Functionally distinct Gata3/Chd4 complexes coordinately establish Th2 cell identity. (P1340)". Journal of Immunology 190, n.º 1_Supplement (1 de maio de 2013): 208.13. http://dx.doi.org/10.4049/jimmunol.190.supp.208.13.
Texto completo da fonteArends, Tessa, Carissa Dege, Alexandra Bortnick, Thomas Danhorn, Jennifer R. Knapp, Haiqun Jia, Laura Harmacek et al. "CHD4 is essential for transcriptional repression and lineage progression in B lymphopoiesis". Proceedings of the National Academy of Sciences 116, n.º 22 (13 de maio de 2019): 10927–36. http://dx.doi.org/10.1073/pnas.1821301116.
Texto completo da fonteO’Shaughnessy, Aoife, e Brian Hendrich. "CHD4 in the DNA-damage response and cell cycle progression: not so NuRDy now". Biochemical Society Transactions 41, n.º 3 (23 de maio de 2013): 777–82. http://dx.doi.org/10.1042/bst20130027.
Texto completo da fonteSmeenk, Godelieve, Wouter W. Wiegant, Hans Vrolijk, Aldo P. Solari, Albert Pastink e Haico van Attikum. "The NuRD chromatin–remodeling complex regulates signaling and repair of DNA damage". Journal of Cell Biology 190, n.º 5 (30 de agosto de 2010): 741–49. http://dx.doi.org/10.1083/jcb.201001048.
Texto completo da fonteMusselman, Catherine A., Robyn E. Mansfield, Adam L. Garske, Foteini Davrazou, Ann H. Kwan, Samuel S. Oliver, Heather O'Leary, John M. Denu, Joel P. Mackay e Tatiana G. Kutateladze. "Binding of the CHD4 PHD2 finger to histone H3 is modulated by covalent modifications". Biochemical Journal 423, n.º 2 (25 de setembro de 2009): 179–87. http://dx.doi.org/10.1042/bj20090870.
Texto completo da fontePratheeshkumar, Poyil, Abdul K. Siraj, Sasidharan Padmaja Divya, Sandeep Kumar Parvathareddy, Khadija Alobaisi, Saif S. Al-Sobhi, Fouad Al-Dayel e Khawla S. Al-Kuraya. "CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC Cells". International Journal of Molecular Sciences 22, n.º 2 (6 de janeiro de 2021): 504. http://dx.doi.org/10.3390/ijms22020504.
Texto completo da fonteHagman, James R., Tessa Arends, Curtis Laborda, Jennifer R. Knapp, Laura Harmacek e Brian P. O’Connor. "Chromodomain helicase DNA‐binding 4 (CHD4) regulates early B cell identity and V(D)J recombination*". Immunological Reviews 305, n.º 1 (20 de dezembro de 2021): 29–42. http://dx.doi.org/10.1111/imr.13054.
Texto completo da fonteQi, Wenjing, Hongyu Chen, Ting Xiao, Ruoxi Wang, Ting Li, Liping Han e Xianlu Zeng. "Acetyltransferase p300 collaborates with chromodomain helicase DNA-binding protein 4 (CHD4) to facilitate DNA double-strand break repair". Mutagenesis 31, n.º 2 (6 de novembro de 2015): 193–203. http://dx.doi.org/10.1093/mutage/gev075.
Texto completo da fonteOyama, Yoshiko, Shogo Shigeta, Hideki Tokunaga, Keita Tsuji, Masumi Ishibashi, Yusuke Shibuya, Muneaki Shimada, Jun Yasuda e Nobuo Yaegashi. "CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents". PLOS ONE 16, n.º 6 (23 de junho de 2021): e0251079. http://dx.doi.org/10.1371/journal.pone.0251079.
Texto completo da fonteHancock, Wayne W., Liqing Wang, Martina Minisini, Eros di Giorgio, Ivan Babic e Elmar Nurmemmedov. "Abstract 2655: Unexpected role of the NuRD component, Chd4, in Foxp3+ Treg cells and its relevance to tumor immunotherapy". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 2655. http://dx.doi.org/10.1158/1538-7445.am2024-2655.
Texto completo da fonteDa Silva, Jorge Diogo, Natália Oliva-Teles, Nataliya Tkachenko, Joana Fino, Mariana Marques, Ana Maria Fortuna e Dezso David. "A Novel Frameshift CHD4 Variant Leading to Sifrim-Hitz-Weiss Syndrome in a Proband with a Subclinical Familial t(17;19) and a Large Dup(2)(q14.3q21.1)". Biomedicines 11, n.º 1 (21 de dezembro de 2022): 12. http://dx.doi.org/10.3390/biomedicines11010012.
Texto completo da fonteYamada, Miki, Noriko Sato, Shinobu Ikeda, Tomio Arai, Motoji Sawabe, Seijiro Mori, Yoshiji Yamada, Masaaki Muramatsu e Masashi Tanaka. "Association of the chromodomain helicase DNA-binding protein 4 (CHD4) missense variation p.D140E with cancer: Potential interaction with smoking". Genes, Chromosomes and Cancer 54, n.º 2 (19 de novembro de 2014): 122–28. http://dx.doi.org/10.1002/gcc.22227.
Texto completo da fonteDenson, Aspin, Matt Parker, WAGNER DIAS, Halyna Fedosyuk, Maria Villar-Lecumberri, Jeff Thompson, Harmony Saunders e Chad Slawson. "Abstract 1049 O-GlcNAc crosslinking of Chromodomain Helicase DNA Binding Protein 4 (CHD4) reveals novel functions for the Nucleosome Chromatin Remodeling Complex". Journal of Biological Chemistry 300, n.º 3 (março de 2024): 106818. http://dx.doi.org/10.1016/j.jbc.2024.106818.
Texto completo da fontePan, Mei-Ren, Hui-Ju Hsieh, Hui Dai, Wen-Chun Hung, Kaiyi Li, Guang Peng e Shiaw-Yih Lin. "Chromodomain Helicase DNA-binding Protein 4 (CHD4) Regulates Homologous Recombination DNA Repair, and Its Deficiency Sensitizes Cells to Poly(ADP-ribose) Polymerase (PARP) Inhibitor Treatment". Journal of Biological Chemistry 287, n.º 9 (4 de janeiro de 2012): 6764–72. http://dx.doi.org/10.1074/jbc.m111.287037.
Texto completo da fonteSingh, Ajeet P., Julie F. Foley, Mark Rubino, Michael C. Boyle, Arpit Tandon, Ruchir Shah e Trevor K. Archer. "Brg1 Enables Rapid Growth of the Early Embryo by Suppressing Genes That Regulate Apoptosis and Cell Growth Arrest". Molecular and Cellular Biology 36, n.º 15 (16 de maio de 2016): 1990–2010. http://dx.doi.org/10.1128/mcb.01101-15.
Texto completo da fonteGuo, Tingting, Daofeng Wang, Jingjing Fang, Jinfeng Zhao, Shoujiang Yuan, Langtao Xiao e Xueyong Li. "Mutations in the Rice OsCHR4 Gene, Encoding a CHD3 Family Chromatin Remodeler, Induce Narrow and Rolled Leaves with Increased Cuticular Wax". International Journal of Molecular Sciences 20, n.º 10 (25 de maio de 2019): 2567. http://dx.doi.org/10.3390/ijms20102567.
Texto completo da fonteYuan, Chih-Chi, Xinyang Zhao, Laurence Florens, Selene K. Swanson, Michael P. Washburn e Nouria Hernandez. "CHD8 Associates with Human Staf and Contributes to Efficient U6 RNA Polymerase III Transcription". Molecular and Cellular Biology 27, n.º 24 (15 de outubro de 2007): 8729–38. http://dx.doi.org/10.1128/mcb.00846-07.
Texto completo da fonteHeshmati, Yaser, Gözde Turköz, Aditya Harisankar, Sten Linnarsson, Marios Dimitriou, Indranil Sinha, Sören Lehmann, Hong Qian e Julian Walfridsson. "Identification of CHD4 As a Potential Therapeutic Target of Acute Myeloid Leukemia". Blood 128, n.º 22 (2 de dezembro de 2016): 1648. http://dx.doi.org/10.1182/blood.v128.22.1648.1648.
Texto completo da fonteSilva, Ana P. G., Daniel P. Ryan, Yaron Galanty, Jason K. K. Low, Marylene Vandevenne, Stephen P. Jackson e Joel P. Mackay. "The N-terminal Region of Chromodomain Helicase DNA-binding Protein 4 (CHD4) Is Essential for Activity and Contains a High Mobility Group (HMG) Box-like-domain That Can Bind Poly(ADP-ribose)". Journal of Biological Chemistry 291, n.º 2 (12 de novembro de 2015): 924–38. http://dx.doi.org/10.1074/jbc.m115.683227.
Texto completo da fonteSchulten, Hans-Juergen, e Sherin Bakhashab. "Meta-Analysis of Microarray Expression Studies on Metformin in Cancer Cell Lines". International Journal of Molecular Sciences 20, n.º 13 (28 de junho de 2019): 3173. http://dx.doi.org/10.3390/ijms20133173.
Texto completo da fonteNio, Kouki, Taro Yamashita e Shuichi Kaneko. "Chromodomain-helicase-DNA-binding protein 4: a novel therapeutic target in liver cancer stem cells". Chinese Clinical Oncology 6, n.º 1 (fevereiro de 2017): 12. http://dx.doi.org/10.21037/cco.2016.07.01.
Texto completo da fonteWong, Sze Chuen Cesar, Moon Tong Cheung, Lewis Lai Yin Luk, Vivian Ha Man Lee, Pak Tat Chan, Hin Fung Andy Tsang, Evelyn Yin Kwan Wong, Vivian Weiwen Xue, Amanda Kit Ching Chan e John Kwok Cheung Chan. "Prognostic significance of Cytokeratin 20-positive lymph node vascular endothelial growth factor A mRNA and chromodomain helicase DNA binding protein 4 in pN0 colorectal cancer patients". Oncotarget 9, n.º 6 (19 de dezembro de 2017): 6737–51. http://dx.doi.org/10.18632/oncotarget.23424.
Texto completo da fonteBagi, Zoltán, Katalin Balog, Bianka Tóth, Milán Fehér, Péter Bársony, Edina Baranyai, Sándor Harangi et al. "Genes and elements involved in the regulation of the nervous system and growth affect the development of spinal deformity in Cyprinus carpio". PLOS ONE 17, n.º 4 (8 de abril de 2022): e0266447. http://dx.doi.org/10.1371/journal.pone.0266447.
Texto completo da fonteNovillo, Apolonia, Ana Fernández-Santander, Maria Gaibar, Miguel Galán, Alicia Romero-Lorca, Fadoua El Abdellaoui-Soussi e Pablo Gómez-del Arco. "Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer". Frontiers in Oncology 11 (26 de abril de 2021). http://dx.doi.org/10.3389/fonc.2021.633233.
Texto completo da fonteHelness, Anne, Jennifer Fraszczak, Charles Joly-Beauparlant, Halil Bagci, Christian Trahan, Kaifee Arman, Peiman Shooshtarizadeh et al. "GFI1 tethers the NuRD complex to open and transcriptionally active chromatin in myeloid progenitors". Communications Biology 4, n.º 1 (dezembro de 2021). http://dx.doi.org/10.1038/s42003-021-02889-2.
Texto completo da fonteLi, Pengyu, Jielin Tang, Zhixin Yu, Cheng Jin, Zhipeng Wang, Mengzhen Li, Dingfeng Zou et al. "CHD4 acts as a critical regulator in the survival of spermatogonial stem cells in mice". Biology of Reproduction, 18 de agosto de 2022. http://dx.doi.org/10.1093/biolre/ioac162.
Texto completo da fonteGeyer, Fabian, Maximilian Geyer, Ute Reuning, Sarah Klapproth, Klaus-Dietrich Wolff e Markus Nieberler. "CHD4 acts as a prognostic factor and drives radioresistance in HPV negative HNSCC". Scientific Reports 14, n.º 1 (9 de abril de 2024). http://dx.doi.org/10.1038/s41598-024-58958-z.
Texto completo da fonteShi, Wei, Angel P. Scialdone, James I. Emerson, Liu Mei, Lauren K. Wasson, Haley A. Davies, Christine E. Seidman, Jonathan G. Seidman, Jeanette G. Cook e Frank L. Conlon. "Missense Mutation in Human CHD4 Causes Ventricular Noncompaction by Repressing ADAMTS1". Circulation Research, 31 de maio de 2023. http://dx.doi.org/10.1161/circresaha.122.322223.
Texto completo da fonteWu, Meng-Ling, Kate Wheeler, Robert Silasi, Florea Lupu e Courtney T. Griffin. "Endothelial Chromatin-Remodeling Enzymes Regulate the Production of Critical ECM Components During Murine Lung Development". Arteriosclerosis, Thrombosis, and Vascular Biology, 13 de junho de 2024. http://dx.doi.org/10.1161/atvbaha.124.320881.
Texto completo da fonteSchilders, Kim A. A., Gabriëla G. Edel, Evelien Eenjes, Bianca Oresta, Judith Birkhoff, Anne Boerema-de Munck, Marjon Buscop-van Kempen et al. "Identification of SOX2 Interacting Proteins in the Developing Mouse Lung With Potential Implications for Congenital Diaphragmatic Hernia". Frontiers in Pediatrics 10 (9 de maio de 2022). http://dx.doi.org/10.3389/fped.2022.881287.
Texto completo da fontePinal-Fernandez, Iago, Jose Cesar Milisenda, Katherine Pak, Sandra Muñoz-Braceras, Maria Casal-Dominguez, Jiram Torres-Ruiz, Stefania Dell'Orso et al. "Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies". Annals of the Rheumatic Diseases, 2 de maio de 2023, ard—2023–223873. http://dx.doi.org/10.1136/ard-2023-223873.
Texto completo da fonteXiao, Guodong, Weiping Lu, Jing Yuan, Zuyue Liu, Peili Wang e Huijie Fan. "Fbxw7 suppresses carcinogenesis and stemness in triple-negative breast cancer through CHD4 degradation and Wnt/β-catenin pathway inhibition". Journal of Translational Medicine 22, n.º 1 (24 de janeiro de 2024). http://dx.doi.org/10.1186/s12967-024-04897-2.
Texto completo da fonteYao, Hui, Douglas F. Hannum, Yiwen Zhai, Sophie F. Hill, Ricardo D. ’Oliveira Albanus, Wenjia Lou, Jennifer M. Skidmore et al. "CHD7 promotes neural progenitor differentiation in embryonic stem cells via altered chromatin accessibility and nascent gene expression". Scientific Reports 10, n.º 1 (15 de outubro de 2020). http://dx.doi.org/10.1038/s41598-020-74537-4.
Texto completo da fonteZhang, Zhen, Flávia C. Costa, Ee Phie Tan, Nathan Bushue, Catherine E. Costello, Mark E. McComb, Stephen A. Whelan, Kenneth R. Peterson e Chad Slawson. "O‐GlcNAc Transferase and O‐GlcNAcase Interact with Mi2β at the Aγ‐Globin Promoter". FASEB Journal 30, S1 (abril de 2016). http://dx.doi.org/10.1096/fasebj.30.1_supplement.803.3.
Texto completo da fonteXu, Weiwei, Weibin Zhou, Haiyang Lin, Dan Ye, Guoping Chen, Fengqin Dong e Jianguo Shen. "A novel heterozygous mutation of CHD7 gene in a Chinese patient with Kallmann syndrome: a case report". BMC Endocrine Disorders 21, n.º 1 (25 de setembro de 2021). http://dx.doi.org/10.1186/s12902-021-00836-0.
Texto completo da fonteLaureano, Alejandra, Jihyun Kim, Edward Martinez e Kelvin Y. Kwan. "Chromodomain Helicase DNA Binding Protein 4 in Cell Fate Decisions". Hearing Research, maio de 2023, 108813. http://dx.doi.org/10.1016/j.heares.2023.108813.
Texto completo da fonteMuhammad, Tahir, Stephen F. Pastore, Katrina Good, Juan Ausió e John B. Vincent. "Chromatin gatekeeper and modifier CHD proteins in development, and in autism and other neurological disorders". Psychiatric Genetics, 16 de outubro de 2023. http://dx.doi.org/10.1097/ypg.0000000000000353.
Texto completo da fonteCoassolo, Sébastien, Guillaume Davidson, Luc Negroni, Giovanni Gambi, Sylvain Daujat, Christophe Romier e Irwin Davidson. "Citrullination of pyruvate kinase M2 by PADI1 and PADI3 regulates glycolysis and cancer cell proliferation". Nature Communications 12, n.º 1 (19 de março de 2021). http://dx.doi.org/10.1038/s41467-021-21960-4.
Texto completo da fonteD’Incal, Claudio Peter, Kirsten Esther Van Rossem, Kevin De Man, Anthony Konings, Anke Van Dijck, Ludovico Rizzuti, Alessandro Vitriolo et al. "Chromatin remodeler Activity-Dependent Neuroprotective Protein (ADNP) contributes to syndromic autism". Clinical Epigenetics 15, n.º 1 (21 de março de 2023). http://dx.doi.org/10.1186/s13148-023-01450-8.
Texto completo da fonteJiang, Dongfang, Tingting Li, Caixia Guo, Tie-Shan Tang e Hongmei Liu. "Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration". Cell & Bioscience 13, n.º 1 (16 de janeiro de 2023). http://dx.doi.org/10.1186/s13578-023-00953-4.
Texto completo da fonteSchulz, Vanessa E., Jeffrey F. Tuff, Riley H. Tough, Lara Lewis, Benjamin Chimukangara, Nigel Garrett, Quarraisha Abdool Karim et al. "Host genetic variation at a locus near CHD1L impacts HIV sequence diversity in a South African population". Journal of Virology, 25 de setembro de 2023. http://dx.doi.org/10.1128/jvi.00954-23.
Texto completo da fonte